352 related articles for article (PubMed ID: 25132073)
1. Transforming growth factor-β1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice.
Zhang Y; Meng XM; Huang XR; Wang XJ; Yang L; Lan HY
Clin Exp Pharmacol Physiol; 2014 Nov; 41(11):921-32. PubMed ID: 25132073
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory skin disease in K5.hTGF-beta1 transgenic mice is not dependent on the IL-23/Th17 inflammatory pathway.
Fitch EL; Rizzo HL; Kurtz SE; Wegmann KW; Gao W; Benson JM; Hinrichs DJ; Blauvelt A
J Invest Dermatol; 2009 Oct; 129(10):2443-50. PubMed ID: 19357708
[TBL] [Abstract][Full Text] [Related]
3. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression.
Jinnin M; Ihn H; Tamaki K
Mol Pharmacol; 2006 Feb; 69(2):597-607. PubMed ID: 16288083
[TBL] [Abstract][Full Text] [Related]
4. The preventive and therapeutic implication for renal fibrosis by targetting TGF-β/Smad3 signaling.
Zhang Y; Meng XM; Huang XR; Lan HY
Clin Sci (Lond); 2018 Jul; 132(13):1403-1415. PubMed ID: 29875262
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of transforming growth factor β1/Smad3 signaling decreases hypoxia-inducible factor-1α protein stability by inducing prolyl hydroxylase 2 expression in human periodontal ligament cells.
Watanabe T; Yasue A; Tanaka E
J Periodontol; 2013 Sep; 84(9):1346-52. PubMed ID: 23088526
[TBL] [Abstract][Full Text] [Related]
6. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X
Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939
[TBL] [Abstract][Full Text] [Related]
7. The long non-coding RNA GAS5 regulates transforming growth factor β (TGF-β)-induced smooth muscle cell differentiation via RNA Smad-binding elements.
Tang R; Zhang G; Wang YC; Mei X; Chen SY
J Biol Chem; 2017 Aug; 292(34):14270-14278. PubMed ID: 28659340
[TBL] [Abstract][Full Text] [Related]
8. Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling.
Ji X; Wang H; Wu Z; Zhong X; Zhu M; Zhang Y; Tan R; Liu Y; Li J; Wang L
Med Sci Monit; 2018 Mar; 24():1633-1641. PubMed ID: 29555895
[TBL] [Abstract][Full Text] [Related]
9. Latent transforming growth factor-β1 protects against bleomycin-induced lung injury in mice.
Tang YJ; Xiao J; Huang XR; Zhang Y; Yang C; Meng XM; Feng YL; Wang XJ; Hui DS; Yu CM; Lan HY
Am J Respir Cell Mol Biol; 2014 Dec; 51(6):761-71. PubMed ID: 24885478
[TBL] [Abstract][Full Text] [Related]
10. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH
Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406
[TBL] [Abstract][Full Text] [Related]
11. Activation of Uterine Smad3 Pathway Is Crucial for Embryo Implantation.
Li J; Dong XY; Yang PW; Yang SL; Hu D; Zhang HW; Sui C
Curr Med Sci; 2019 Dec; 39(6):997-1002. PubMed ID: 31845233
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
13. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
14. Role of Transforming Growth Factor-β1 and Smads Signaling Pathway in Intrauterine Adhesion.
Salma U; Xue M; Ali Sheikh MS; Guan X; Xu B; Zhang A; Huang L; Xu D
Mediators Inflamm; 2016; 2016():4158287. PubMed ID: 26997760
[TBL] [Abstract][Full Text] [Related]
15. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
16. TGF-β1/Smad3 Signaling Pathway Mediates T-2 Toxin-Induced Decrease of Type II Collagen in Cultured Rat Chondrocytes.
Li Y; Zou N; Wang J; Wang KW; Li FY; Chen FX; Sun BY; Sun DJ
Toxins (Basel); 2017 Nov; 9(11):. PubMed ID: 29113082
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice.
Singh TP; Huettner B; Koefeler H; Mayer G; Bambach I; Wallbrecht K; Schön MP; Wolf P
Am J Pathol; 2011 Feb; 178(2):699-708. PubMed ID: 21281802
[TBL] [Abstract][Full Text] [Related]
18. Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.
Niu L; Cui X; Qi Y; Xie D; Wu Q; Chen X; Ge J; Liu Z
PLoS One; 2016; 11(5):e0156090. PubMed ID: 27224286
[TBL] [Abstract][Full Text] [Related]
19. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22.
Honma M; Minami-Hori M; Takahashi H; Iizuka H
J Dermatol Sci; 2012 Feb; 65(2):134-40. PubMed ID: 22189341
[TBL] [Abstract][Full Text] [Related]
20. Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model.
Nakajima K; Kanda T; Takaishi M; Shiga T; Miyoshi K; Nakajima H; Kamijima R; Tarutani M; Benson JM; Elloso MM; Gutshall LL; Naso MF; Iwakura Y; DiGiovanni J; Sano S
J Immunol; 2011 Apr; 186(7):4481-9. PubMed ID: 21346238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]